Belal Azab

2.5k total citations
62 papers, 1.8k citations indexed

About

Belal Azab is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Belal Azab has authored 62 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 17 papers in Genetics and 14 papers in Oncology. Recurrent topics in Belal Azab's work include Virus-based gene therapy research (11 papers), RNA Interference and Gene Delivery (6 papers) and CAR-T cell therapy research (6 papers). Belal Azab is often cited by papers focused on Virus-based gene therapy research (11 papers), RNA Interference and Gene Delivery (6 papers) and CAR-T cell therapy research (6 papers). Belal Azab collaborates with scholars based in United States, Jordan and South Korea. Belal Azab's co-authors include Devanand Sarkar, Paul B. Fisher, Swadesh K. Das, Rupesh Dash, Sujit K. Bhutia, Zhao-zhong Su, Seok‐Geun Lee, David T. Curiel, Tareq Saleh and B. N. Prashanth Kumar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biomaterials.

In The Last Decade

Belal Azab

57 papers receiving 1.8k citations

Peers

Countries citing papers authored by Belal Azab

Since Specialization

Citations

This map shows the geographic impact of Belal Azab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belal Azab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belal Azab more than expected).

Fields of papers citing papers by Belal Azab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belal Azab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belal Azab. The network helps show where Belal Azab may publish in the future.

Co-authorship network of co-authors of Belal Azab

This figure shows the co-authorship network connecting the top 25 collaborators of Belal Azab. A scholar is included among the top collaborators of Belal Azab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belal Azab. Belal Azab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic profiling of Wilson disease reveals a potential recurrent pathogenic variant of ATP7B in the Jordanian population 2025 ·Journal of Pediatric Gastroenterology and Nutrition ·Fareed Ahmad, (unknown), Yaser Rayyan, Tarek Tamimi, (unknown), (unknown), (unknown), Belal Azab	0
2	A three-marker signature identifies senescence in human breast cancer exposed to neoadjuvant chemotherapy 2023 ·Cancer Chemotherapy and Pharmacology ·(unknown), (unknown), (unknown), Nisreen Abu Shahin, (unknown), Mohammad A. Ismail, Nidaa A. Ababneh, Moureq R. Alotaibi, Belal Azab, Tareq Saleh	17
3	Potential Composite Digenic Contribution of NPC1 and NOD2 Leading to Atypical Lethal Niemann-Pick Type C with Initial Crohn’s Disease-like Presentation: Genotype-Phenotype Correlation Study 2022 ·Genes ·Belal Azab, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ma’mon M. Hatmal, (unknown)	4
4	Investigating the genetic profile of familial atypical cystic fibrosis patients (DeltaF508-CFTR) with neonatal biliary atresia 2022 ·Journal of Applied Genetics ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Belal Azab	1
5	A homozygous variant in ABCA3 is associated with severe respiratory distress and early neonatal death 2021 ·Congenital Anomalies ·Montaha Al‐Iede, (unknown), (unknown), Raja Rabah, Mousa A. Al‐Abbadi, Belal Azab, Eman Badran	1
6	Identification of APTX disease-causing mutation in two unrelated Jordanian families with cerebellar ataxia and sensitivity to DNA damaging agents 2020 ·PLoS ONE ·Nidaa A. Ababneh, (unknown), (unknown), Malik Sallam, (unknown), (unknown), (unknown), Belal Azab, Basil Sharrack, Abdalla Awidi	4
7	PKM2 and HIF-1α regulation in prostate cancer cell lines 2018 ·PLoS ONE ·(unknown), (unknown), Nafez Abu Tarboush, (unknown), Oleg Pak, Belal Azab	39
8	Novel frameshift variant in the IDUA gene underlies Mucopolysaccharidoses type I in a consanguineous Yemeni pedigree 2017 ·Molecular Genetics and Metabolism Reports ·Belal Azab, (unknown), (unknown), Mohammad Alsalem, Zaid Kilani, (unknown), Abdalla Awidi, Hanan Jafar, Sami S. Amr	3
9	Targeted Apoptotic Effects of Thymoquinone and Tamoxifen on XIAP Mediated Akt Regulation in Breast Cancer 2013 ·PLoS ONE ·Shashi Rajput, B. N. Prashanth Kumar, Siddik Sarkar, Subhasis Das, Belal Azab, Prasanna K. Santhekadur, Swadesh K. Das, Luni Emdad, Devanand Sarkar, Paul B. Fisher, Mahitosh Mandal	104
10	Chemoprevention Gene Therapy (CGT): Novel Combinatorial Approach for Preventing and Treating Pancreatic Cancer 2013 ·Current Molecular Medicine ·Siddik Sarkar, Belal Azab, Swadesh K. Das, Barry Quinn, (unknown), Rupesh Dash, Luni Emdad, (unknown), (unknown), (unknown), (unknown), Devanand Sarkar, P B Fisher	8
11	Raf Kinase Inhibitor RKIP Inhibits MDA-9/Syntenin-Mediated Metastasis in Melanoma 2012 ·Cancer Research ·Swadesh K. Das, Sujit K. Bhutia, Upneet K. Sokhi, Belal Azab, Zhao-zhong Su, Habib Boukerche, Talha Anwar, Erika L. Moen, Devasis Chatterjee, Maurizio Pellecchia, Devanand Sarkar, Paul B. Fisher	49
12	MDA-9/Syntenin and IGFBP-2 Promote Angiogenesis in Human Melanoma 2012 ·Cancer Research ·Swadesh K. Das, Sujit K. Bhutia, Belal Azab, Timothy P. Kegelman, (unknown), Prasanna K. Santhekadur, Santanu Dasgupta, Rupesh Dash, Paul Dent, Steven Grant, Luni Emdad, Maurizio Pellecchia, Devanand Sarkar, Paul B. Fisher	79
13	Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda -7/IL-24–mediated toxicity 2011 ·Proceedings of the National Academy of Sciences ·Rupesh Dash, Belal Azab, Bridget A. Quinn, Xue‐Ning Shen, Xiangyang Wang, Swadesh K. Das, Mohamed Rahmani, Jun Wei, Michael Hedvat, Paul Dent, Igor P. Dmitriev, David T. Curiel, Steven Grant, Bainan Wu, John L. Stebbins, Maurizio Pellecchia, John C. Reed, Devanand Sarkar, Paul B. Fisher	101
14	The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer 2011 ·Biomaterials ·P. Venkatesan, Nagaprasad Puvvada, Rupesh Dash, B. N. Prashanth Kumar, Devanand Sarkar, Belal Azab, Amita Pathak, Subhas C. Kundu, Paul B. Fisher, Mahitosh Mandal	215
15	Mechanism of Autophagy to Apoptosis Switch Triggered in Prostate Cancer Cells by Antitumor Cytokine Melanoma Differentiation-Associated Gene 7/Interleukin-24 2010 ·Cancer Research ·Sujit K. Bhutia, Rupesh Dash, Swadesh K. Das, Belal Azab, Zhao-zhong Su, Seok‐Geun Lee, Steven Grant, Adly Yacoub, Paul Dent, David T. Curiel, Devanand Sarkar, Paul B. Fisher	102
16	Mechanism by Which Mcl-1 Regulates Cancer-Specific Apoptosis Triggered by mda-7/IL-24, an IL-10–Related Cytokine 2010 ·Cancer Research ·Rupesh Dash, Joanna E. Richards, Zhao-zhong Su, Sujit K. Bhutia, Belal Azab, Mohamed Rahmani, Girija Dasmahapatra, Adly Yacoub, Paul Dent, Igor P. Dmitriev, David T. Curiel, Steven Grant, Maurizio Pellecchia, John C. Reed, Devanand Sarkar, Paul B. Fisher	65
17	Human polynucleotide phosphorylase (hPNPaseold-35): an evolutionary conserved gene with an expanding repertoire of RNA degradation functions 2010 ·Oncogene ·Swadesh K. Das, Sujit K. Bhutia, Upneet K. Sokhi, Rupesh Dash, Belal Azab, Devanand Sarkar, Paul B. Fisher	19
18	Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells 2010 ·Cancer Gene Therapy ·Rupesh Dash, Igor P. Dmitriev, (unknown), Sujit K. Bhutia, Belal Azab, Nicollaq Vozhilla, Adly Yacoub, P Dent, David T. Curiel, Devanand Sarkar, Paul B. Fisher	42
19	mda-7/IL-24: A unique member of the IL-10 gene family promoting cancer-targeted toxicity 2010 ·Cytokine & Growth Factor Reviews ·Rupesh Dash, Sujit K. Bhutia, Belal Azab, Zhao-zhong Su, Bridget A. Quinn, (unknown), Swadesh K. Das, (unknown), Seok‐Geun Lee, Margaret A. Park, Adly Yacoub, Mohamed Rahmani, Luni Emdad, Igor P. Dmitriev, Xiang‐Yang Wang, Devanand Sarkar, Steven Grant, Paul Dent, David T. Curiel, Paul B. Fisher	91
20	Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1 2010 ·Oncogene ·Rupesh Dash, (unknown), Seok‐Geun Lee, Belal Azab, Habib Boukerche, Devanand Sarkar, Paul B. Fisher	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact